CIK 0001681682
- Non-accelerated filer
- Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 260579295
- Phone
- +1 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 4 Option exercise Chief Financial Officer acquired 5,000 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 2,874 shares (option exercise)
- 4 Conversion Director acquired 11,386 shares (conversion)
- 4 Conversion Chief Financial Officer acquired 10,350 shares (conversion)
- 4 Conversion Chief Technology Officer acquired 51,747 shares (conversion)
- 4 Conversion Chief Executive Officer acquired 5,175 shares (conversion)
- 4 Open-market buy Director bought 5,000 shares at $0.92 ($4,600)
- 4 Open-market buy Director bought 10,000 shares at $0.90 ($9,000)
- 4 Open-market buy Director bought 5,000 shares at $0.90 ($4,500)
- 4 Open-market buy Director bought 10,000 shares at $0.91 ($9,100)
- 4 Open-market buy Director bought 10,000 shares at $0.85 ($8,500)
- 4 Open-market buy Director bought 10,000 shares at $0.82 ($8,200)
- 4 Open-market buy Director bought 10,000 shares at $0.78 ($7,800)
- 4 Open-market buy Director bought 10,000 shares at $0.71 ($7,100)
- 4 Grant or award Director acquired 41,587 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 42,857 shares (grant or award)
- 4 Grant or award Director acquired 42,857 shares (grant or award)
- 4 Grant or award Director acquired 42,857 shares (grant or award)
- 4 Grant or award Director acquired 42,857 shares (grant or award)
Page 5 of 9 · 174 filings